We’re focused on three goals: transforming knowledge into medicines that make a
difference for patients, creating value that will inspire the continued support of our
fellow shareholders, and building a team that passionately pursues excellence.
important franchises, including
IBS-C/CIC, refractory GERD,
uncontrolled gout, and vascular
and fibrotic diseases.